References
- 1. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997; 2:341-4.
- 2. McHutchison JG. Understanding Hepatitis C. Am J Manag Care. 2004; 10:S21-29.
- 3. Nair S, Perillo RP. Hepatitis B and D. In: Zakim D, Boyer TD, eds. Hepatology. 4th ed. Philadelphia: Saunders, 2003.
- 4. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol. 2007; 13:74-81.10.3748/wjg.v13.i1.74
- 5. Hu KQ, Yang H, Lin YC, Lindsay KL, Redeker AG. Clinical profiles of chronic Hepatitis C in a major county medical center outpatient setting in United States. Int J Med Sci. 2004; 1:92-100.10.7150/ijms.1.92
- 6. Alter M. Epidemiology of hepatitis B infec-tion in the Western Pacific and South-East Asia. Gut. 1976; 38 (suppl. 2):S18-23.
- 7. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004; 127: S27-34.10.1053/j.gastro.2004.09.013
- 8. Wang CS, Chang TT, Yao WJ, Chou P. Comparison of Hepatitis B Virus and Hepatitis C Virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg. 2002; 66:389-93.
- 9. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334:1691-6.10.1056/NEJM199606273342602
- 10. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992; 327:1899-905.10.1056/NEJM199212313272702
- 11. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A casecontrol study. J Gastroenterol and Hepatol. 2002; 17: 1092-7.10.1046/j.1440-1746.2002.02843.x
- 12. Cooreman MP, Schoondermark-Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol. 1996; Suppl. 218:106-15.
- 13. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepatitis Monthly. 2008; 8:281-94.
- 14. Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine. 2002; 20:3739-43.10.1016/S0264-410X(02)00358-4
- 15. Arslanoglu I, Cetin B, Isguven P, Karavus M. Anti- HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab. 2002; 15:389-95.10.1515/JPEM.2002.15.4.389
- 16. Cook IF, Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants. J Paediatr Child Health. 2002; 38:393-6.10.1046/j.1440-1754.2002.00013.x
- 17. Farhat A, Khademi G, Mazouman SJ. The prevalence of hepatitis B carrier state in Khorasan province of Iran. Saudi Med J. 2003; 24:549-51.
- 18. Amini S Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population-based study. J Trop Med Hyg. 1993; 96:277-87.
- 19. Mojtahedzadeh SM. Prevalence of HBsAg and VDRL positive cases in Hamadan province blood donors. Journal of research in medicine, Shaheed Beheshti University of Medical Sciences, 1995; 3,4:74 [Article in Persian language].
- 20. Othman BM, Monem FS. Prevalence of hepatitis virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Med J. 2002; 23: 393-5.
- 21. Haider NA. Prevalence of HBV and C among blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23:1090-4.
- 22. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 2003; 49: 440-7.
- 23. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in North Indian voluntary and replacement blood donors: prevalence and trends, 1989-1996. Vox Sang. 1997; 73:70-3.10.1046/j.1423-0410.1997.7320070.x
- 24. Khokhar N, Gill ML, Malik GJ. General se--roprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak. 2004; 14:534-6.
- 25. Ashgar A. Prevalence of hepatitis B virus genotype in Saudi Arabia: a preliminary report. Indian J Gastroenterol. 2008; 27:81-2.